Healthcare
Blue Sky Scrubs Launches Sickle Cell Awareness Fundraising Campaign During National Awareness Month
Blue Sky Scrubs is dedicating September to sickle cell disease awareness through a fundraising initiative that directs proceeds from scrub sales to research and support programs while educating the public about this hereditary blood disorder.
AHS Interpreter Services Manager Sambo Ly Receives KPIX Icon Award for Decades of Community Service
Sambo Ly, manager of interpreter services at Alameda Health System, has been honored with KPIX's Icon Award for her decades of work breaking down language barriers and serving refugees and immigrants in one of America's most diverse counties.
Soligenix Advances Oral Mucositis Treatment SGX942 with Combined Clinical Data Analysis
Soligenix is leveraging positive phase 2 and 3 clinical data to design a second pivotal trial for SGX942, addressing the critical unmet medical need for oral mucositis treatment in cancer patients.
Lantern Pharma Completes Japan Enrollment in Phase 2 Trial for Never-Smoker Lung Cancer Treatment
Lantern Pharma has achieved targeted patient enrollment in Japan for its Phase 2 HARMONIC trial evaluating LP-300 in never-smoker non-small cell lung cancer patients, marking significant progress in addressing an underserved population with high unmet medical need.
Oncotelic Therapeutics Advances Late-Stage Oncology Pipeline Under Proven Leadership
Oncotelic Therapeutics is progressing multiple late-stage clinical programs in high-unmet-need oncology indications under CEO Dr. Vuong Trieu, whose track record with blockbuster cancer drugs positions the company for potential therapeutic breakthroughs.
UCLA Researchers Awarded $2M Grant for MRI-Guided Cancer Radiation Therapy Study
UCLA Health receives a $2 million grant from ViewRay Systems to advance research on MRI-guided radiation therapy for targeted cancer treatment, highlighting growing investment in precision oncology technologies.
Nutriband Secures FDA Meeting for Abuse-Deterrent Fentanyl Patch Development
Nutriband Inc. has obtained FDA approval for a Type C meeting regarding its AVERSA™ abuse-deterrent fentanyl patch technology, marking a significant regulatory milestone in addressing opioid abuse through transdermal pharmaceutical innovation.
Oncotelic Therapeutics CEO's Patent Portfolio and Track Record Position Company for Oncology Market Growth
Oncotelic Therapeutics' CEO Dr. Vuong Trieu, developer of Abraxane, brings extensive patent expertise and successful drug development experience that strengthens the company's position in advancing innovative cancer therapies with significant market potential.
Izotropic Corporation Secures $375,000 in Private Placement for Breast Cancer Imaging Development
Izotropic Corporation has closed a $375,000 private placement to fund development of its breast cancer screening technology, supporting advancements in medical imaging accuracy.
Insilico Medicine CEO Outlines Path to Pharmaceutical Superintelligence as AI-Discovered Drugs Advance Through Clinical Trials
Insilico Medicine's CEO details how generative AI is transforming drug discovery, compressing development timelines and advancing multiple clinical programs, with the first fully AI-designed drugs potentially reaching patients within five to six years.
Lexaria's DehydraTECH Shows Enhanced Brain Delivery of Semaglutide in Preclinical Study
Lexaria Bioscience's drug delivery technology demonstrated improved brain distribution of GLP-1 drug semaglutide in rodents, potentially leading to better safety and efficacy for weight loss treatments.
ABVC BioPharma Reports $1.28 Million in Q3 Licensing Revenue, Strengthening High-Margin Business Model
ABVC BioPharma has collected $1.28 million in Q3 licensing revenues from multiple partners, including OncoX BioPharma, demonstrating the profitability of its licensing framework with minimal incremental costs.
Creative Biolabs Expands IVD Capabilities with Integrated Protein and Nucleic Acid Detection
Creative Biolabs has enhanced its in vitro diagnostics services by integrating protein and nucleic acid detection technologies, offering researchers more comprehensive biomarker analysis for early disease detection and complex condition research.
Creative Biolabs Accelerates CAR-T Therapy Innovation with Advanced Development Platform
Creative Biolabs is enhancing CAR-T therapy research through its comprehensive development platform, offering specialized viral vectors and ready-made plasmids that address critical challenges in scalability, cost, and technical efficiency for both blood cancers and emerging solid tumor applications.
Viromed Medical AG Achieves ISO 13485 Certification, Clears Path for ViroCAP® Market Launch
Viromed Medical AG's ISO 13485 certification enables independent market entry for its ViroCAP® cold plasma medical devices, positioning the company for accelerated growth in dermatology and veterinary markets starting October 2025.
Alzheimer's Community Care Secures Funding to Expand Day Center Services for 58 New Participants
Alzheimer's Community Care has obtained new funding to cover specialized day center attendance for up to 58 additional participants with dementia-related disorders, providing crucial respite for caregivers and expanding access to therapeutic services in South Florida.
LabConnect Appoints Industry Veteran Bill Finger to Lead Global Strategic Services
LabConnect has appointed Bill Finger as Senior Vice President of Global Strategic Services, bringing over 25 years of diagnostics and clinical research expertise to enhance the company's capabilities in complex clinical trials.
Shala Hormone Health Expands to Canada, Marking First International Launch
Shala Hormone Health's expansion into Canada provides Canadian women access to science-backed wellness products focused on hormonal balance and gut health, representing the company's first international market entry.
Beachway Therapy Center Hosts Trauma Recovery Panel Discussion on Healing from Abuse and Addiction
Beachway Therapy Center in West Palm Beach is hosting a complimentary panel discussion on trauma recovery, featuring author Tricia Youngs' book 'Rescued: Hope for the Shattered Heart and Soul' to provide practical insights and strategies for healing from abuse and addiction.
Plus Therapeutics Subsidiary CNSide Diagnostics Achieves CLIA Accreditation for CNS Cancer Testing Lab
CNSide Diagnostics has received CMS accreditation for its clinical laboratory, enabling broader patient access and insurance coverage for its cerebrospinal fluid assay platform used in central nervous system cancer detection.
Quantum BioPharma Receives Health Canada Product License for Qlarity Natural Health Product
Quantum BioPharma Ltd. has secured Health Canada approval for its Qlarity natural health product, expanding its market reach and revenue potential through regulatory clearance for cognitive and energy support supplements.
Dietary Protein Restriction May Enhance Glioblastoma Treatment Efficacy, Study Finds
University of Michigan research indicates that low-protein diets combined with serine-free protein shakes could improve chemotherapy and radiation outcomes for glioblastoma patients by making tumors more vulnerable to treatment.
McKesson Restructures Business Segments to Focus on High-Growth Healthcare Areas
McKesson Corporation is reorganizing its reporting structure to enhance strategic alignment and transparency, focusing on accelerating growth in oncology, multispecialty, and biopharma services while optimizing portfolio management for long-term shareholder value.
American Heart Association Awards Scholarships to Student Leaders Promoting Heart Health
The American Heart Association has awarded $1,000 scholarships to five high school students nationwide for their leadership in promoting cardiovascular health, addressing the critical need to combat rising risk factors among young Americans.
Oncotelic Therapeutics Advances Cancer Research with AI and Nanomedicine Pipeline
Oncotelic Therapeutics is leveraging artificial intelligence and nanomedicine to develop innovative treatments for aggressive cancers and rare pediatric diseases, backed by a substantial intellectual property portfolio.
Streamline Scientific Launches Enhanced PCR Reporting Service to Combat Antibiotic Misuse in UTI Treatment
Streamline Scientific's new PCR reporting service integrates clinical guidelines directly into test results to help physicians make more informed antibiotic prescribing decisions for urinary tract infections, addressing the critical issue of antimicrobial resistance.
GeoVax's CM04S1 Vaccine Shows Promise for Immunocompromised Patients in Phase 2 Trials
GeoVax Labs' next-generation COVID-19 vaccine candidate demonstrates superior immune responses in immunocompromised patients compared to mRNA vaccines, potentially addressing critical gaps in current vaccination strategies.
Maryland Faces Critical Healthcare, Judicial, and Energy Policy Decisions
Maryland confronts multiple policy challenges including potential healthcare cost increases for ACA enrollees, judicial sentencing debates, and threats to offshore wind development, all with significant implications for residents and the state's economy.
Sturgeon Family Foundation Distributes Over $34,000 to Fort Worth Charities with Focus on Women, Canine Welfare, and Entrepreneurship
The Sturgeon Family Foundation's significant donations to local Fort Worth charities highlight its strategic philanthropic approach across four key focus areas while promoting awareness of alternative cancer treatments through its dedicated website.
Walmart and Sam's Club Campaign Raises $378,000 for Atlanta Food Bank Addressing Growing Hunger Crisis
Walmart and Sam's Club's annual Fight Hunger. Spark Change. campaign raised $378,000 for the Atlanta Community Food Bank, providing over 1.1 million meals to address the critical food insecurity affecting 1 in 8 people in metro Atlanta and north Georgia.